Thurber Greg M, Zajic Stefan C, Wittrup K Dane
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
J Nucl Med. 2007 Jun;48(6):995-9. doi: 10.2967/jnumed.106.037069. Epub 2007 May 15.
Targeting tumors with antibody-based therapeutics is a complex task presenting multiple kinetic barriers. Antibody internalization and clearance inhibit uptake both in solid tumors, limited by tumor vascular permeability, and in micrometastases, limited by diffusion.
A modeling exercise is used to introduce 2 simple criteria that must be less than unity for saturation of both tumors and micrometastases. The clearance modulus and the Thiele modulus are ratios of the plasma clearance rate and antibody catabolism, respectively, to the tumor tissue penetration rate.
Even low rates of antigen internalization from constitutive membrane turnover can significantly retard antibody penetration. Rapid clearance of single-chain variable fragments also hinders uptake, often more than counterbalancing their more rapid extravasation and diffusion.
The model illustrates that with the large resistance from the tumor capillary, antibodies may be more suitable for targeting micrometastases than vascularized tumors.
使用基于抗体的疗法靶向肿瘤是一项复杂的任务,存在多种动力学障碍。抗体的内化和清除在实体瘤(受肿瘤血管通透性限制)和微转移灶(受扩散限制)中均会抑制摄取。
采用一种建模方法引入两个简单标准,对于肿瘤和微转移灶的饱和,这两个标准必须小于1。清除模量和西勒模量分别是血浆清除率与抗体分解代谢率和肿瘤组织穿透率的比值。
即使是来自组成性膜更新的低抗原内化率也会显著阻碍抗体穿透。单链可变片段的快速清除也会阻碍摄取,其阻碍程度通常超过其更快的血管外渗和扩散所带来的平衡作用。
该模型表明,由于肿瘤毛细血管存在较大阻力,抗体可能比血管化肿瘤更适合靶向微转移灶。